• About
  • Subscribe
  • Advertise
  • Contact
Monday, March 16, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Applications open for OA program to develop glaucoma expertise

by Staff Writer
February 27, 2026
in Associations, Eye disease, Glaucoma, Local, News, Ophthalmic education, Ophthalmic insights, Ophthalmic organisations
Reading Time: 3 mins read
A A
The program is for optometrists with advanced glaucoma experience. Image: Yakobchuk Olena/stock.adobe.com.

The program is for optometrists with advanced glaucoma experience. Image: Yakobchuk Olena/stock.adobe.com.

Share on FacebookShare on Twitter

Optometry Australia (OA) is encouraging members with advanced experience in glaucoma care to apply for its Advanced Practice Recognition (APR) program, with applications for the first 2026 intake now open.

In a media release, OA said the member-exclusive initiative was a cornerstone of its long-term vision for the profession, designed to formally recognise optometrists with advanced clinical expertise while supporting career progression and workforce sustainability.

“The APR program keeps experienced optometrists engaged, creates clear advanced career pathways and improves collaboration within optometry and across professions, within the existing workforce,” said Dr Nicola Anstice, director of education and research at OA,

“By recognising expertise in glaucoma care, the APR program enables optometrists to manage more complex cases in collaborative models by building leadership depth and positioning the profession to play a greater role in meeting eye health demand.”

Graduates of the program will earn the Optometry Australia Credentialled Advanced Practitioner – Glaucoma (OACAP-G) credential, signifying Optometry Australia Credentialled Advanced Practitioner – Glaucoma (OACAP-G), signalling their expertise in managing more complex glaucoma cases in clinical practice.

A pathway for advanced clinical recognition

The release said the program had been established as part of OA’s efforts to realise its preferred future for optometry in 2040, supporting long-term career planning, professional growth and retention of highly skilled clinicians within the profession.

“The APR program empowers optometrists to be recognised for advanced practice while delivering high-quality, evidence-based glaucoma care within their existing scope of practice,” Dr Anstice said.

“It’s a forward-looking initiative that supports lifelong learning and the evolving role of optometry in Australia’s eye healthcare landscape.”

Strengthening collaboration and patient access

The program is also designed to strengthen collaborative care pathways between optometrists and ophthalmologists, helping to improve timely access to care for patients with glaucoma.

Credentialled practitioners can use the OACAP-G title and logo, gain access to exclusive symposia and peer networks and unlock opportunities in education, speaking and future program assessment roles.

“By formally recognising advanced expertise, we can enhance co-management opportunities, streamline referrals and ultimately improve patient outcomes,” Dr Anstice said.

“These benefit not only individual practitioners, but also the broader health system and community by supporting more efficient, team-based care.”

Who is eligible to apply?

To be eligible, applicants must be:

  • An active OA member;
  • A therapeutically endorsed optometrist registered to practise in Australia or New Zealand;
  • Have a minimum of five years’ clinical experience;
  • Demonstrate advanced experience in glaucoma care management;
  • Commit to completing the program over approximately four months (with part-time options considered on a case-by-case basis).

A pathway to recognition

OA said two intake rounds would run in 2026, one commencing in March and the other in July/August, with applications reviewed on a rolling basis and capped at 20 candidates per round.

To begin the assessment process, members must submit an application form, CV and cover letter to apr@optometry.org.au.

Once accepted into the round, successful applicants will then be required to:

  1. Provide evidence of clinical experience in glaucoma through patient case logs and/or recognition of prior experience.
  2. Submit two case reports (maximum 3,000 words each).
  3. Demonstrate leadership competencies.
  4. Participate in a clinical discussion Interview.

For further information or support with the application process, members can visit OA’s website on the APR program or contact the APR team at apr@optometry.org.au.

Applications close Monday, 23 March.

Related Posts

Optos ultra-widefield imaging will be on show at events in Western Australia and NSW. Image: Prime Creative Media.

Optos technology on show in upcoming events

by Staff Writer
March 16, 2026

Optos is encouraging eyecare professionals serious about advancing patient care and staying ahead in eye health technology to visit its...

The eye drops can quickly relieve tired, red eyes. Image: LimeSky/stock.adobe.com.

B+L announces launch of Lumify eye drops in Australia

by Staff Writer
March 16, 2026

Bausch + Lomb (B+L) has announced the Australian launch of Lumify redness reliever eye drops in April. The Lumify range...

Dry eye can be exacerbated or even present for the first time after cataract surgery. Image: Pormezz/stock.adobe.com

Dry Eye Society announces Melbourne launch event

by Staff Writer
March 16, 2026

The Dry Eye Society (DES) has announced its official Melbourne launch event, bringing together eye care professionals with a shared interest...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited